# VertiFlex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vertiflex

- Industry: Medical Devices & Equipment
- Headquarters: Carlsbad, US
- Website: www.vertiflexspine.com
- Total disclosed funding: $76M
- Latest round: Series E (May 16, 2011)
- Investors on record: 5

## About

VertiFlex Inc. is a medical device company that specializes in innovative solutions for spinal health, focused on improving patient outcomes in chronic pain management.Founded in 2005 and headquartered in Carlsbad, US, VertiFlex Inc. develops advanced technologies for spinal health. In May 2019, the company was acquired by Boston Scientific Corporation for USD 465 mn. The firm has completed a total of 14 deals, with the most recent agreement occurring on May 9, 2019. The founder’s prior entrepreneurial history is not publicly detailed.VertiFlex Inc. specializes in advanced medical technologies, particularly in pain management. Its core offerings include the WaveWriter Alpha™ Spinal Cord Stimulator System and the Intracept™ Procedure for intraosseous nerve ablation. These products are designed to address chronic pain conditions like failed back surgery syndrome and diabetic peripheral neuropathy, among others.VertiFlex Inc. generates revenue through direct sales to healthcare providers and medical facilities, focusing on B2B transactions. Its products are sold to hospitals and clinics, which purchase advanced medical devices for patient management. Revenue is enhanced through partnerships and educational programs that support device utilization and engagement.Following the recent acquisition, VertiFlex Inc. will leverage the expertise and resources of Boston Scientific to design and launch new products aimed at expanding its market presence. The company plans to target new geographic regions, particularly in Europe and select areas in Asia, with initiatives expected to roll out by 2021. The USD 465 mn funding from the acquisition will be utilized to accelerate product development and support market entry strategies.

## Funding rounds

- Series E, May 16, 2011, $14M — Alta Partners, New Enterprise Associates, Aberdare Ventures, Thomas, McNerney & Partners
- Series D, Feb 3, 2011, $5.6M — Alta Partners, New Enterprise Associates, Aberdare Ventures, Thomas, McNerney & Partners
- Series D, Dec 15, 2010, $8.4M — Alta Partners, Morgenthaler Ventures, Aberdare Ventures
- Series C, Jun 18, 2008, $28M — Alta Partners, Morgenthaler Ventures, New Enterprise Associates, Aberdare Ventures
- Series B, Dec 21, 2006, $20M — Alta Partners, Morgenthaler Ventures, Aberdare Ventures

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B, Series C, Series D, Series E
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series B, Series C, Series D
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series B, Series C, Series D, Series E
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series C, Series D, Series E
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series D, Series E